Cargando…
Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B(2) receptor and peptidase resistance in rats
Maximakinin (MK), an amphibian peptide possessing the C-terminal sequence of bradykinin (BK), is a BK B(2) receptor (B(2)R) agonist eliciting prolonged signaling. We reinvestigated this 19-mer for species-specific pharmacologic profile, in vivo confirmation of resistance to inactivation by angiotens...
Autores principales: | Charest-Morin, Xavier, Bachelard, Hélène, Jean, Melissa, Marceau, Francois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248581/ https://www.ncbi.nlm.nih.gov/pubmed/28133580 http://dx.doi.org/10.7717/peerj.2911 |
Ejemplares similares
-
In Vivo Effects of Bradykinin B(2) Receptor Agonists with Varying Susceptibility to Peptidases
por: Jean, Mélissa, et al.
Publicado: (2016) -
Infrared-emitting, peptidase-resistant fluorescent ligands of the bradykinin B(2) receptor: application to cytofluorometry and imaging
por: Gera, Lajos, et al.
Publicado: (2016) -
D-Arg(0)-Bradykinin-Arg-Arg, a Latent Vasoactive Bradykinin B(2) Receptor Agonist Metabolically Activated by Carboxypeptidases
por: Bachelard, Hélène, et al.
Publicado: (2018) -
In Vitro Modeling of Bradykinin-Mediated Angioedema States
por: Marceau, François, et al.
Publicado: (2020) -
Pharmacological evidence of bradykinin regeneration from extended sequences that behave as peptidase–activated B(2) receptor agonists
por: Charest-Morin, Xavier, et al.
Publicado: (2014)